Elevatus Welath Management’s Amgen AMGN Stock Holding History

Elevatus Welath Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$361K	Buy	+998	New	+$342K	0.09%	158

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Elevatus Welath Management's AMGN Position: Q2 2026 in Review

Elevatus Welath Management opened a new position in Amgen (AMGN) in Q2 2026: 998 shares worth $361K. The stake represents 0.09% of the portfolio and ranks #158 among its holdings.

3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Elevatus Welath Management held 998 shares of Amgen worth $361K as of Q2 2026.
Amgen was a new Elevatus Welath Management position in Q2 2026.
Amgen made up 0.09% of Elevatus Welath Management's portfolio in Q2 2026, its #158 holding.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Elevatus Welath Management's 13F filing for Q2 2026, filed 13 Aug 2026.